These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31884469)

  • 21. Psychotic symptoms in frontotemporal dementia: prevalence and review.
    Mendez MF; Shapira JS; Woods RJ; Licht EA; Saul RE
    Dement Geriatr Cogn Disord; 2008; 25(3):206-11. PubMed ID: 18204254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very-late-onset psychotic symptoms: psychosis or dementia? A phenomenological approach. A systematic review.
    Belbeze J; Gallarda T
    Geriatr Psychol Neuropsychiatr Vieil; 2020 Mar; 18(1):77-86. PubMed ID: 32876568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.
    Lopez OL; Brenner RP; Becker JT; Ulrich RF; Boller F; DeKosky ST
    Neurology; 1997 Jun; 48(6):1521-5. PubMed ID: 9191759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurobiology of neuropsychiatric syndromes in dementia.
    Meeks TW; Ropacki SA; Jeste DV
    Curr Opin Psychiatry; 2006 Nov; 19(6):581-6. PubMed ID: 17012935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosis in Alzheimer's disease.
    Murray PS; Kumar S; Demichele-Sweet MA; Sweet RA
    Biol Psychiatry; 2014 Apr; 75(7):542-52. PubMed ID: 24103379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study.
    Sweet RA; Bennett DA; Graff-Radford NR; Mayeux R;
    Brain; 2010 Apr; 133(Pt 4):1155-62. PubMed ID: 20147454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric symptoms in the dementias.
    Assal F; Cummings JL
    Curr Opin Neurol; 2002 Aug; 15(4):445-50. PubMed ID: 12151841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychotic symptoms and Alzheimer's disease].
    Alberca R; Gil-Néciga E; Salas D; Pérez JA; Lozano P
    Neurologia; 2000 Jan; 15(1):8-14. PubMed ID: 10730061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus.
    Kales HC; Lyketsos CG; Miller EM; Ballard C
    Int Psychogeriatr; 2019 Jan; 31(1):83-90. PubMed ID: 30068400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review.
    Showraki A; Murari G; Ismail Z; Barfett JJ; Fornazzari L; Munoz DG; Schweizer TA; Fischer CE
    J Alzheimers Dis; 2019; 71(2):477-501. PubMed ID: 31424398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms.
    Ballard C; Youakim JM; Coate B; Stankovic S
    J Prev Alzheimers Dis; 2019; 6(1):27-33. PubMed ID: 30569083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosis and physical aggression in probable Alzheimer's disease.
    Deutsch LH; Bylsma FW; Rovner BW; Steele C; Folstein MF
    Am J Psychiatry; 1991 Sep; 148(9):1159-63. PubMed ID: 1882992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer's disease, part I: symptom clusters.
    Garre-Olmo J; López-Pousa S; Vilalta-Franch J; de Gracia Blanco M; Vilarrasa AB
    J Alzheimers Dis; 2010; 22(4):1157-67. PubMed ID: 20930289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients.
    Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Clin Psychiatry; 2016 Jan; 77(1):e8-13. PubMed ID: 26845282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Bayesian model of psychosis symptom trajectory in Alzheimer's disease.
    Seltman HJ; Mitchell S; Sweet RA
    Int J Geriatr Psychiatry; 2016 Feb; 31(2):204-10. PubMed ID: 26216660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical variables associated with psychosis in Alzheimer's disease.
    Kotrla KJ; Chacko RC; Harper RG; Doody R
    Am J Psychiatry; 1995 Sep; 152(9):1377-9. PubMed ID: 7653698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer disease subjects with psychosis have increased schizotypal symptoms before dementia onset.
    Eror EA; Lopez OL; Dekosky ST; Sweet RA
    Biol Psychiatry; 2005 Aug; 58(4):325-30. PubMed ID: 15978552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.